Proto Labs (PRLB) Sets New 12-Month High at $156.53

Share on StockTwits

Shares of Proto Labs Inc (NYSE:PRLB) reached a new 52-week high during trading on Tuesday . The company traded as high as $156.53 and last traded at $156.20, with a volume of 117004 shares trading hands. The stock had previously closed at $155.45.

Separately, Zacks Investment Research upgraded shares of Proto Labs from a “hold” rating to a “buy” rating and set a $137.00 price objective for the company in a research report on Friday, August 3rd. Two investment analysts have rated the stock with a hold rating, two have issued a buy rating and one has issued a strong buy rating to the company. The stock has an average rating of “Buy” and a consensus price target of $104.33.

The company has a market cap of $4.20 billion, a PE ratio of 80.14, a PEG ratio of 2.93 and a beta of 1.22.

Proto Labs (NYSE:PRLB) last issued its earnings results on Thursday, July 26th. The industrial products company reported $0.73 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.72 by $0.01. Proto Labs had a net margin of 15.98% and a return on equity of 13.55%. The business had revenue of $109.65 million during the quarter, compared to the consensus estimate of $110.46 million. During the same period last year, the business posted $0.49 EPS. Proto Labs’s revenue was up 33.7% on a year-over-year basis. sell-side analysts anticipate that Proto Labs Inc will post 2.65 earnings per share for the current fiscal year.

In other Proto Labs news, VP Robert Bodor sold 3,000 shares of the stock in a transaction dated Tuesday, June 12th. The shares were sold at an average price of $130.00, for a total value of $390,000.00. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director John B. Goodman sold 1,113 shares of the stock in a transaction dated Thursday, June 14th. The shares were sold at an average price of $131.50, for a total transaction of $146,359.50. Following the completion of the transaction, the director now directly owns 12,655 shares in the company, valued at $1,664,132.50. The disclosure for this sale can be found here. Insiders sold a total of 18,457 shares of company stock valued at $2,612,722 over the last quarter. 0.64% of the stock is currently owned by company insiders.

Institutional investors and hedge funds have recently made changes to their positions in the company. Summit Trail Advisors LLC increased its holdings in shares of Proto Labs by 10,537.9% during the first quarter. Summit Trail Advisors LLC now owns 175,100 shares of the industrial products company’s stock worth $175,000 after purchasing an additional 173,454 shares during the period. SG Americas Securities LLC bought a new position in shares of Proto Labs during the first quarter worth approximately $188,000. Nwam LLC acquired a new stake in shares of Proto Labs during the 2nd quarter worth approximately $201,000. Meeder Asset Management Inc. boosted its position in shares of Proto Labs by 342.6% during the 2nd quarter. Meeder Asset Management Inc. now owns 1,735 shares of the industrial products company’s stock worth $206,000 after acquiring an additional 1,343 shares in the last quarter. Finally, First Republic Investment Management Inc. acquired a new stake in shares of Proto Labs during the 2nd quarter worth approximately $241,000. 96.84% of the stock is currently owned by institutional investors.

About Proto Labs (NYSE:PRLB)

Proto Labs, Inc, together with its subsidiaries, operates as an e-commerce enabled digital manufacturer of custom parts for prototyping and short-run production worldwide. It utilizes injection molding, computer numerical control machining, three-dimensional (3D) printing, and sheet metal fabrication to manufacture custom parts for developers and engineers who use 3D computer-aided design software to design products across a range of end markets.

Further Reading: Stock Symbol

Receive News & Ratings for Proto Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply